Sung et al., 2004 - Google Patents
Proteomic analysis of differential protein expression in neuropathic pain and electroacupuncture treatment modelsSung et al., 2004
- Document ID
- 9461339555976477644
- Author
- Sung H
- Kim Y
- Kim I
- Jang S
- Kim Y
- Na D
- Han K
- Hwang B
- Park D
- Ko J
- Publication year
- Publication venue
- Proteomics
External Links
Snippet
Acupuncture has long been used for pain relief. Although recent studies have shown that acupuncture can reduce neuropathic pain, the mechanism of this effect is not clear and little information is available regarding proteins that are involved in the development of …
- 102000004169 proteins and genes 0 title abstract description 81
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sung et al. | Proteomic analysis of differential protein expression in neuropathic pain and electroacupuncture treatment models | |
Parmelee et al. | Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein | |
Swerdlow et al. | Substantia innominata: Critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat | |
Silhol et al. | Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats | |
Domenici et al. | Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion | |
US4923696A (en) | Method to prepare a neurotrophic composition | |
US20160046704A1 (en) | Glycoproteins having lipid mobilising properties and therapeutic applications thereof | |
US4701407A (en) | Diagnosis of Alzheimer disease | |
ATE297983T1 (en) | DIAGNOSIS AND TREATMENT OF DISEASE USING ANTI-T CELL RECEPTOR VBETA ANTIBODIES OR PEPTIDES TO WHICH THESE ANTIBODIES SPECIFICALLY BIND AND ESRP1 | |
Bolwig et al. | Synaptic proteins after electroconvulsive stimulation: Reversibility and regional differences in the brain | |
Samorajski et al. | Neurochemistry of aging | |
Volpina et al. | A fragment of the receptor for advanced glycation end products restores the spatial memory of animals in a model of Alzheimer’s disease | |
Juorio et al. | The effect of mesencephalic lesions on tyramine and dopamine in the caudate nucleus of the rat | |
Coni et al. | Thymosin β4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study | |
Carleson et al. | Effects of adjuvant on neuropeptide-like immunoreactivity in experimentally induced temporomandibular arthritis in rats | |
Cai et al. | Age‐related changes of aqueous protein profiles in rat fast and slow twitch skeletal muscles | |
Talavera et al. | NADPH-diaphorase-stained neurons after experimental epilepsy in rats | |
Lima et al. | Spatial distribution of glutamate, taurine and GABA in teleosts and mammals retina: in vivo and in vitro study | |
JPH06504285A (en) | neuronal cholinergic differentiation factor | |
Barmack et al. | Activity-dependent expression of calbindin in rabbit floccular Purkinje cells modulated by optokinetic stimulation | |
Pivnik et al. | Alteration of intraerythrocyte proteolytic degradation of hemoglobin during Hodgkin's disease | |
Kaldany et al. | Proteolytic processing of a peptide precursor in Aplysia neuron R14. | |
Lewis et al. | Regional brain concentrations of calcitonin gene-related peptide in spontaneously hypertensive and normotensive Wistar-Kyoto rats | |
US6573243B1 (en) | Pompilid wasp-derived neuropeptides | |
Simonato et al. | Time‐and region‐specific variations in somatostatin release following amygdala kindling in the rat |